T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Toll Brothers
TOL
$14B
| $9.24M | ﹤0.01% |
234,980
-7,930
| -3% | -$290K |
|
|
ESV
1352
DELISTED
Ensco Rowan plc
ESV
| $9.23M | ﹤0.01% |
109,473
+7,592
| +7% | +$800K |
|
1353
Transocean
RIG
$6.39B
| $9.15M | ﹤0.01% |
623,545
+56,845
| +10% | +$921K |
|
1354
Designer Brands
DBI
$312M
| $9.13M | ﹤0.01% |
247,562
+28,700
| +13% | +$1.05M |
|
1355
MBIA
MBI
$262M
| $9.1M | ﹤0.01% |
978,750
+935,700
| +2,174% | +$8.33M |
|
|
CTRX
1356
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $9.09M | ﹤0.01% |
152,732
-3,100
| -2% | -$158K |
|
|
CRZO
1357
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $9.03M | ﹤0.01% |
181,900
+27,700
| +18% | +$1.3M |
|
|
AIRM
1358
DELISTED
Air Methods Corp
AIRM
| $9.02M | ﹤0.01% |
193,600
-2,392,951
| -93% | -$110M |
|
1359
Ryder
R
$10.1B
| $8.93M | ﹤0.01% |
94,075
+11,900
| +14% | +$1.09M |
|
|
WIN
1360
DELISTED
Windstream Holdings Inc
WIN
| $8.81M | ﹤0.01% |
152,053
+3,145
| +2% | +$200K |
|
|
WLH
1361
DELISTED
WILLIAM LYON HOMES
WLH
| $8.77M | ﹤0.01% |
339,800
+128,800
| +61% | +$2.78M |
|
1362
Ulta Beauty
ULTA
$22.2B
| $8.77M | ﹤0.01% |
58,151
+7,239
| +14% | +$1M |
|
|
HCBK
1363
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $8.76M | ﹤0.01% |
835,589
+25,900
| +3% | +$253K |
|
1364
TriplePoint Venture Growth BDC
TPVG
$221M
| $8.71M | ﹤0.01% |
616,987
+152,800
| +33% | +$2.23M |
|
|
INFI
1365
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $8.71M | ﹤0.01% |
622,720
-269,350
| -30% | -$4.12M |
|
|
MR
1366
DELISTED
Montage Resources Corporation Common Stock
MR
| $8.67M | ﹤0.01% |
102,849
-164,051
| -61% | -$15.6M |
|
|
SNMX
1367
DELISTED
Senomyx, Inc.
SNMX
| $8.64M | ﹤0.01% |
1,958,265
+22,400
| +1% | +$117K |
|
|
SLH
1368
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $8.59M | ﹤0.01% |
166,350
+12,900
| +8% | +$680K |
|
1369
Pegasystems
PEGA
$5.51B
| $8.48M | ﹤0.01% |
780,000
+36,200
| +5% | +$374K |
|
1370
Nu Skin
NUS
$236M
| $8.48M | ﹤0.01% |
140,847
-14,190
| -9% | -$722K |
|
1371
Avery Dennison
AVY
$13.6B
| $8.37M | ﹤0.01% |
158,191
-325
| -0.2% | -$17.2K |
|
|
TE
1372
DELISTED
TECO ENERGY INC
TE
| $8.34M | ﹤0.01% |
429,785
+3,000
| +0.7% | +$60.6K |
|
|
INVX
1373
Innovex International
INVX
$2.15B
| $8.31M | ﹤0.01% |
121,500
-10,300
| -8% | -$742K |
|
|
SPN
1374
DELISTED
Superior Energy Services, Inc.
SPN
| $8.28M | ﹤0.01% |
37,061
+28,174
| +317% | +$5.85M |
|
|
ABAX
1375
DELISTED
Abaxis Inc
ABAX
| $8.24M | ﹤0.01% |
128,600
+122,300
| +1,941% | +$7.45M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.